Nebraska Hematology-Oncology (NHO) — Lincoln, Nebraska

Nebraska Hematology-Oncology (NHO) is a clinical research site located in Lincoln, Nebraska, United States 68506.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Hematology-Oncology (NHO) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Extensive-stage Small-cell Lung Cancer.

Sponsors: BioNTech SE.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Hematology-Oncology (NHO)?

Nebraska Hematology-Oncology (NHO) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Hematology-Oncology (NHO) conducted?

Nebraska Hematology-Oncology (NHO) has 1 clinical trials on record, with 1 currently active. Their work covers Extensive-stage Small-cell Lung Cancer.

Is Nebraska Hematology-Oncology (NHO) accredited by Crixeo Health?

Nebraska Hematology-Oncology (NHO) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Hematology-Oncology (NHO)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.